Clostridium butyricum: A Potential Treatment for Sepsis
Author Information
Author(s): Zhao Jinglin, Jiang Li, He Weizhi, Han Dingrui, Yang Xuan, Wu Liuli, Zhong Haiyan
Primary Institution: Kunming Children’s Hospital, Children’s Hospital Affiliated to Kunming Medical University, Kunming, Yunnan, China
Hypothesis
Can Clostridium butyricum serve as a therapeutic agent in the treatment of sepsis?
Conclusion
Clostridium butyricum shows promise as a probiotic that could help in the treatment of sepsis by regulating intestinal microecology and enhancing immune function.
Supporting Evidence
- Clostridium butyricum has been shown to inhibit pathogenic bacteria and promote beneficial bacteria in the gut.
- It produces metabolites like butyric acid that help maintain intestinal health and improve immune function.
- Research indicates that it may alleviate conditions like inflammatory bowel disease and colorectal cancer.
Takeaway
Clostridium butyricum is a good bacteria that can help our bodies fight infections like sepsis by keeping our gut healthy.
Methodology
This review evaluates the role and mechanisms of Clostridium butyricum in human diseases, particularly focusing on its potential in sepsis treatment.
Limitations
The protective effect of Clostridium butyricum on sepsis is still in the basic research stage in animal models, and its role in humans needs further clinical investigation.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website